Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma

Head and Neck

Volumn 34, Issue 10, 2012, Pages 1369-1371

  Giovanella, Luca ^a,b,c   Toffalori, Emanuela ^c,d   Tozzoli, Renato ^c,e   Caputo, Marco ^c,f   Ceriani, Luca ^a   Verburg, Frederik A ^g  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^c Endocrinology and Metabolism Study Group of Italian Society of Laboratory Medicine (SIMeL)   (Italy)

^d Azienda Provinciale per i Servizi Sanitari Provincia Autonoma di Trento ^*  (Italy)

^e City Hospital   (Italy)

^f Department of Clinical Chemistry and Microbiology   (Italy)

^g UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

differentiated thyroid carcinoma; immunoassay; multiplexed; thyroglobulin; thyroglobulin antibodies

Indexed keywords

THYROGLOBULIN ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLEXED IMMUNOASSAY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; LINEAR MODELS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84866378465     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21933     Document Type: Article

References (10)

1. Grebe SKG,. Diagnosis and management of thyroid carcinoma: focus on serum thyroglobulin. Expert Rev Endocrinol Metab 2009; 4: 25-43.
2. Spencer C,. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab 2004; 89: 3702-3704. (Pubitemid 39071459)
3. Spencer C, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS,. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005; 90: 5566-5575. (Pubitemid 41415459)
4. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W,. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803. (Pubitemid 43997716)
5. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
6. Krahn J, Dembinski T,. Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem 2009; 42: 416-419.
7. Spencer C, Petrovic I, Fatemi S,. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 2011; 96: 1283-1291.
8. Gonzalez-Buitrago J,. Multiplexed testing in the autoimmunity laboratory. Clin Chem Lab Med 2006; 44: 1169-1174. (Pubitemid 44580796)
9. Lalvani A, Meroni PL, Millington KA, et al. Recent advances in diagnostic technology: applications in autoimmune and infectious diseases. Clin Exp Rheumatol 2008; 26 (Suppl 48): S62-S66. (Pubitemid 351578097)
10. Tozzoli R, Villalta D, Kodermaz G, Bagnasco M, Tonutti M, Bizzarro N,. Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method. Clin Chem Lab Med 2006; 44: 837-842.